These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 22260386)
21. PAX2 and PAX8: useful markers for metastatic effusions. Waters L; Crumley S; Truong L; Mody D; Coffey D Acta Cytol; 2014; 58(1):60-6. PubMed ID: 24334997 [TBL] [Abstract][Full Text] [Related]
22. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma. Geramizadeh B; Ravanshad M; Rahsaz M Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673 [TBL] [Abstract][Full Text] [Related]
23. PAX8 expression in sporadic hemangioblastoma of the kidney supports a primary renal cell lineage: implications for differential diagnosis. Zhao M; Williamson SR; Yu J; Xia W; Li C; Zheng J; Zhu Y; Sun K; Wang Z; Cheng L Hum Pathol; 2013 Oct; 44(10):2247-55. PubMed ID: 23849894 [TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical markers for the differential diagnosis of nephrogenic adenomas. Quinones W; Ziober A; Yao Y; Bing Z Ann Diagn Pathol; 2013 Feb; 17(1):41-4. PubMed ID: 22672805 [TBL] [Abstract][Full Text] [Related]
25. Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma. Chang A; Brimo F; Montgomery EA; Epstein JI Hum Pathol; 2013 Aug; 44(8):1563-8. PubMed ID: 23453625 [TBL] [Abstract][Full Text] [Related]
26. Recent advances of immunohistochemistry for diagnosis of renal tumors. Kuroda N; Tanaka A; Ohe C; Nagashima Y Pathol Int; 2013 Aug; 63(8):381-90. PubMed ID: 23957913 [TBL] [Abstract][Full Text] [Related]
27. Role Of Immunohistochemistry In Subtyping Renal Cell Carcinomas With Overlapping Morphological Features. Tariq N; Mamoon N; Haroon A; Ali Z; Ahmad IN J Ayub Med Coll Abbottabad; 2018; 30(3):325-332. PubMed ID: 30465359 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution. Paner GP; Srigley JR; Radhakrishnan A; Cohen C; Skinnider BF; Tickoo SK; Young AN; Amin MB Am J Surg Pathol; 2006 Jan; 30(1):13-9. PubMed ID: 16330937 [TBL] [Abstract][Full Text] [Related]
29. Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma. Ordóñez NG Mod Pathol; 2013 Aug; 26(8):1132-43. PubMed ID: 23503645 [TBL] [Abstract][Full Text] [Related]
30. Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study. Al-Ahmadie HA; Alden D; Fine SW; Gopalan A; Touijer KA; Russo P; Reuter VE; Tickoo SK Am J Surg Pathol; 2011 Jul; 35(7):949-61. PubMed ID: 21677535 [TBL] [Abstract][Full Text] [Related]
31. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution. Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401 [TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical profile of common epithelial neoplasms arising in the kidney. Kim MK; Kim S Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):332-8. PubMed ID: 12613443 [TBL] [Abstract][Full Text] [Related]
33. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases. Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012 [TBL] [Abstract][Full Text] [Related]
34. Immunohistochemistry for the novel markers glypican 3, PAX8, and p40 (ΔNp63) in squamous cell and urothelial carcinoma. Gailey MP; Bellizzi AM Am J Clin Pathol; 2013 Dec; 140(6):872-80. PubMed ID: 24225756 [TBL] [Abstract][Full Text] [Related]
35. GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics. Mantilla JG; Antic T; Tretiakova M Hum Pathol; 2017 Aug; 66():152-158. PubMed ID: 28705707 [TBL] [Abstract][Full Text] [Related]
36. Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma. Peat TJ; Edmondson EF; Miller MA; DuSold DM; Ramos-Vara JA Vet Pathol; 2017 Jul; 54(4):588-594. PubMed ID: 28346124 [TBL] [Abstract][Full Text] [Related]
37. Profiling and classification tree applied to renal epithelial tumours. Allory Y; Bazille C; Vieillefond A; Molinié V; Cochand-Priollet B; Cussenot O; Callard P; Sibony M Histopathology; 2008 Jan; 52(2):158-66. PubMed ID: 18036175 [TBL] [Abstract][Full Text] [Related]
38. A comprehensive analysis of PAX8 expression in human epithelial tumors. Laury AR; Perets R; Piao H; Krane JF; Barletta JA; French C; Chirieac LR; Lis R; Loda M; Hornick JL; Drapkin R; Hirsch MS Am J Surg Pathol; 2011 Jun; 35(6):816-26. PubMed ID: 21552115 [TBL] [Abstract][Full Text] [Related]
39. Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology. Knoepp SM; Kunju LP; Roh MH Diagn Cytopathol; 2012 Aug; 40(8):667-72. PubMed ID: 22807381 [TBL] [Abstract][Full Text] [Related]
40. Malignant tumors with clear cell morphology: a comparative immunohistochemical study with renal cell carcinoma antibody, Pax8, steroidogenic factor 1, and brachyury. Clayton EF; Ziober A; Yao Y; Bing Z Ann Diagn Pathol; 2013 Apr; 17(2):192-7. PubMed ID: 23218904 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]